Clinical Gastroenterology and Hepatology
Volume 7, Issue 9 , Pages 966-971, September 2009

Stratifying Risk for Celiac Disease in a Large At-Risk United States Population by Using HLA Alleles

  • Michelle M. Pietzak

      Affiliations

    • Department of Pediatrics, Women's and Children's Hospital, University of Southern California Keck School of Medicine, Los Angeles
    • Corresponding Author InformationReprint requests Address requests for reprints to: Michelle Pietzak, MD, LAC+USC Healthcare Network, Interns/Residents Building, Room 137, 2020 Zonal Avenue, Los Angeles, California 90033. fax: (323) 226-5692
  • ,
  • Timothy C. Schofield

      Affiliations

    • Prometheus Laboratories Inc, San Diego, California
  • ,
  • Matthew J. McGinniss

      Affiliations

    • Prometheus Laboratories Inc, San Diego, California
  • ,
  • Robert M. Nakamura

      Affiliations

    • Prometheus Laboratories Inc, San Diego, California

published online 04 June 2009.

Background & Aims

Susceptibility to celiac disease (CD) is related to HLA-DQ2 and DQ8 alleles and the heterodimers they encode. The objective of this study was to stratify risk for CD on the basis of HLA-DQ genotype.

Methods

DNA from 10,191 subjects who are at risk for CD was analyzed for HLA-DQ haplotypes. Individuals with CD were identified as those who tested positive for anti-endomysial immunoglobulin A (EMA+) in an immunofluorescence assay.

Results

Samples homozygous for DQ2.5 (HLA-DQA1*05-DQB1*02) or DQ2.2/DQ2.5 (HLA-DQA1*05-DQB1*02 and HLA-DQA1*0201-DQB1*02) comprised 5.38% of the total; 28.28% of these were EMA+ (95% confidence interval [CI], 24.55–32.26). Of the samples that were DQ2.5 heterozygous (HLA-DQA1*05-DQB1*02); 9.09% were EMA+ (95% CI, 7.82–10.51). Among samples in which HLA-DQ8 (HLA-DQA1*03-DQB1*0302) was detected, 8.42% of homozygotes (95% CI, 3.71–15.92) and 2.11% of heterozygotes (95% CI, 1.43–3.00) were EMA+. Samples with DQ2.2/DQ8 or DQ2.5/DQ8 comprised 5.08% of the total, and 11.78% of these were EMA+ (95% CI, 9.13–14.87). HLA-DQ2 and HLA-DQ8 were absent in 4283 samples (42.03% of the total); 0.16% of these samples were EMA+ (95% CI, 0.07–0.34).

Conclusions

High-resolution, sequence-specific oligonucleotide probe typing with 35 DQA1-specific and 37 DQB1-specific probes of DNA from more than 10,000 subjects was used to stratify risk of CD in an at-risk U.S. population. DQ2 homozygosity (DQ2.5/DQ2.2+2.5) increased risk for CD, estimated by the rate of EMA positivity, compared with the entire sample population and other DQ genotypes. These data suggest a quantitative relationship between the type/proportion of DQ heterodimers and the risk of CD and identify potential immunotherapeutic targets.

To view this article's video abstract, go to the AGA's YouTube Channel.

Abbreviations used in this paper: CD, celiac disease, CI, confidence interval, EMA, anti-endomysial IgA antibody, GFD, gluten-free diet

 

 Conflicts of interest The authors disclose the following: Michelle Pietzak has received research support, acts as a consultant for, and has received honoraria from the speaker's bureau of Prometheus Laboratories Inc. Timothy C. Schofield, Matthew J. McGinniss, and Robert M. Nakamura are employees of Prometheus Laboratories Inc.

 Funding This manuscript was supported by an unrestricted grant from Prometheus Laboratories Inc. Editorial assistance and statistical analysis were provided by MDG Development Group. Prometheus Laboratories Inc provided financial support for this assistance.

PII: S1542-3565(09)00482-0

doi:10.1016/j.cgh.2009.05.028

Refers to article:

  • Video AbstractAdditional Online Content AvailableLinking Article with CGH Analysis of HLA and Non-HLA Alleles Can Identify Individuals at High Risk for Celiac Disease , 18 May 2009

    Jihane Romanos, Cleo C. van Diemen, Ilja M. Nolte, Gosia Trynka, Alexandra Zhernakova, Jingyuan Fu, Maria Teresa Bardella, Donatella Barisani, Ross McManus, David A. van Heel, Cisca Wijmenga
    Gastroenterology September 2009 (Vol. 137, Issue 3, Pages 834-840.e3)

Clinical Gastroenterology and Hepatology
Volume 7, Issue 9 , Pages 966-971, September 2009